NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
David H Adams
Eli Lilly and Company - Indianapolis / United States
Others
AD Scientific Index ID: 4393969
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
David H Adams's MOST POPULAR ARTICLES
1-)
Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial …B Doft, T Nakamura, AF WalonkerArchives of ophthalmology 113 (12), 1479-1496, 199512931995
2-)
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 …VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ...The lancet Respiratory medicine 9 (12), 1407-1418, 20216742021
3-)
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised …P Nash, B Kirkham, M Okada, P Rahman, B Combe, GR Burmester, ...The Lancet 389 (10086), 2317-2327, 20174482017
4-)
Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factorsSS Newton, EF Collier, J Hunsberger, D Adams, R Terwilliger, ...Journal of Neuroscience 23 (34), 10841-10851, 20034452003
5-)
Volume I. introduction to DUNEB Abi, R Acciarri, MA Acero, G Adamov, D Adams, M Adinolfi, Z Ahmad, ...Journal of instrumentation 15 (08), T08008, 20204412020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept